SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-20-002598
Accepted
2020-09-30 00:15:09
Documents
1
Effectiveness Date
2020-09-29
Registration Form
POS AM
Reference AccNo
0001193125-20-255644

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 607
  Complete submission text file 9999999995-20-002598.txt   1709
Mailing Address 220 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 220 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Filer) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-234038 | Film No.: 201210513
SIC: 2834 Pharmaceutical Preparations